Rivaroxaban for Patients with Intermittent Claudication.
Eduardo RamacciottiGiuliano Giova VolpianiKaren Falcão BrittoLeandro Barile AgatiCamilla Moreira RibeiroValéria Cristina Resende AguiarAlexia PaganottiFelipe Menegueti PereiraRoberto Augusto CaffaroRogério KrakauerHeron Rhydan Saad RachedJawed FareedNelson WoloskerSonia S AnandJohn W EikelboomChiann ChangRenato D LopesPublished in: NEJM evidence (2024)
In patients with peripheral artery disease and intermittent claudication, 2.5 mg of rivaroxaban twice daily plus 100 mg of aspirin daily improved the total walking distance by a 6-minute walking test compared with 100 mg of aspirin daily alone. (Funded by Bayer S.A.; Clinicaltrials.gov number, NCT04853719.).